Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with ra...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5505756bedc747a0b0d401f3350bbc48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5505756bedc747a0b0d401f3350bbc48 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5505756bedc747a0b0d401f3350bbc482021-12-02T11:43:36ZCopy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy10.1038/s41598-020-75869-x2045-2322https://doaj.org/article/5505756bedc747a0b0d401f3350bbc482020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-75869-xhttps://doaj.org/toc/2045-2322Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with radical cystectomy (RC), using multiplex ligation-dependent probe amplification (MLPA). We hypothesized that primary tumor and lymph node metastasis show similar CNV profiles, and CNV are more present in lymph node metastasis compared to primary tumor tissue. Samples from 43 (59.7%) patients could be analyzed. In total, 35 (83%), 26 (68%) and 8 (42%) patients had CNV in primary tumor, serum and lymph node metastasis, respectively. MYC, CCND1, ERBB2 and CCNE1 displayed the most frequent amplifications. In particular, CNV in ERBB2 was associated with aggressive tumor characteristics. CNV in both ERBB2 and TOP2A were risk factors for disease recurrence. The current findings show that CNV are present in various oncogenes and tumor suppressor genes in genomic DNA from primary tumor, lymph node metastasis and cfDNA from serum. CNV were more present in genomic DNA from primary tumor tissue compared to cfDNA from serum and genomic DNA from lymph node metastasis. Patients with CNV in ERBB2 and TOP2A are at increased risk for disease recurrence following RC. Further studies are necessary to validate, whether these genes may represent promising candidates for targeted-therapy.Armin SoaveLan KluweHang YuMichael RinkPhilipp GildMalte W. VetterleinPhilipp MarksGuido SauterMargit FischChristian P. MeyerTim LudwigRoland DahlemSarah MinnerKlaus PantelBettina SteinbachHeidi SchwarzenbachNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Armin Soave Lan Kluwe Hang Yu Michael Rink Philipp Gild Malte W. Vetterlein Philipp Marks Guido Sauter Margit Fisch Christian P. Meyer Tim Ludwig Roland Dahlem Sarah Minner Klaus Pantel Bettina Steinbach Heidi Schwarzenbach Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
description |
Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with radical cystectomy (RC), using multiplex ligation-dependent probe amplification (MLPA). We hypothesized that primary tumor and lymph node metastasis show similar CNV profiles, and CNV are more present in lymph node metastasis compared to primary tumor tissue. Samples from 43 (59.7%) patients could be analyzed. In total, 35 (83%), 26 (68%) and 8 (42%) patients had CNV in primary tumor, serum and lymph node metastasis, respectively. MYC, CCND1, ERBB2 and CCNE1 displayed the most frequent amplifications. In particular, CNV in ERBB2 was associated with aggressive tumor characteristics. CNV in both ERBB2 and TOP2A were risk factors for disease recurrence. The current findings show that CNV are present in various oncogenes and tumor suppressor genes in genomic DNA from primary tumor, lymph node metastasis and cfDNA from serum. CNV were more present in genomic DNA from primary tumor tissue compared to cfDNA from serum and genomic DNA from lymph node metastasis. Patients with CNV in ERBB2 and TOP2A are at increased risk for disease recurrence following RC. Further studies are necessary to validate, whether these genes may represent promising candidates for targeted-therapy. |
format |
article |
author |
Armin Soave Lan Kluwe Hang Yu Michael Rink Philipp Gild Malte W. Vetterlein Philipp Marks Guido Sauter Margit Fisch Christian P. Meyer Tim Ludwig Roland Dahlem Sarah Minner Klaus Pantel Bettina Steinbach Heidi Schwarzenbach |
author_facet |
Armin Soave Lan Kluwe Hang Yu Michael Rink Philipp Gild Malte W. Vetterlein Philipp Marks Guido Sauter Margit Fisch Christian P. Meyer Tim Ludwig Roland Dahlem Sarah Minner Klaus Pantel Bettina Steinbach Heidi Schwarzenbach |
author_sort |
Armin Soave |
title |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
title_short |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
title_full |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
title_fullStr |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
title_full_unstemmed |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
title_sort |
copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/5505756bedc747a0b0d401f3350bbc48 |
work_keys_str_mv |
AT arminsoave copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT lankluwe copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT hangyu copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT michaelrink copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT philippgild copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT maltewvetterlein copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT philippmarks copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT guidosauter copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT margitfisch copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT christianpmeyer copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT timludwig copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT rolanddahlem copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT sarahminner copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT klauspantel copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT bettinasteinbach copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy AT heidischwarzenbach copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy |
_version_ |
1718395341530726400 |